Abstract
| Original language | English |
|---|---|
| Article number | 795439 |
| Pages (from-to) | 1-5 |
| Number of pages | 5 |
| Journal | Anemia |
| Volume | 2012 |
| DOIs | |
| Publication status | Published - 2012 |
| Externally published | Yes |
Fingerprint
Cite this
}
Prevalence of Anemia and Risk of Adverse Bleeding Effect of Drugs : Implication for Therapy. / Nwose, Ezekiel (Uba).
In: Anemia, Vol. 2012, 795439, 2012, p. 1-5.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Prevalence of Anemia and Risk of Adverse Bleeding Effect of Drugs
T2 - Implication for Therapy
AU - Nwose, Ezekiel (Uba)
PY - 2012
Y1 - 2012
N2 - This study aimed to evaluate the progress in reduction of prevalence of anemia in rural Australia. It also investigates the prevalence of hypoviscosity in anaemia with a view to determine the fraction of anaemic patients at risk of drug-inducible exacerbation of anemia. Archived clinical pathology data ( = 1 3 0 , 3 5 4 ) for the period of 1999 to 2008 were utilized. The prevalence of anemia and hypoviscosity was evaluated by working out (i) the number that fell within anemia definition as a percentage of the population and (ii) the number that fell within hypoviscosity definition as a percentage of anemic patients. The prevalence in anemic diabetes and dyslipidaemia was further determined. There was progressive reduction in anemia from 6.1% to 3.2% over the ten years period. Prevalence of anemia is statistically significantly higher in males than in females ( < 0 . 0 0 0 1 ), but protein level is lower in anemic females than in anemic males ( < 0 . 0 1 ). The results further show that up to 75% of anemic patients may benefit from NSAID or salicylates. This paper highlights differences between genders. It suggests more concerted effort in men's health and speculates a new factor to investigate in women's health.
AB - This study aimed to evaluate the progress in reduction of prevalence of anemia in rural Australia. It also investigates the prevalence of hypoviscosity in anaemia with a view to determine the fraction of anaemic patients at risk of drug-inducible exacerbation of anemia. Archived clinical pathology data ( = 1 3 0 , 3 5 4 ) for the period of 1999 to 2008 were utilized. The prevalence of anemia and hypoviscosity was evaluated by working out (i) the number that fell within anemia definition as a percentage of the population and (ii) the number that fell within hypoviscosity definition as a percentage of anemic patients. The prevalence in anemic diabetes and dyslipidaemia was further determined. There was progressive reduction in anemia from 6.1% to 3.2% over the ten years period. Prevalence of anemia is statistically significantly higher in males than in females ( < 0 . 0 0 0 1 ), but protein level is lower in anemic females than in anemic males ( < 0 . 0 1 ). The results further show that up to 75% of anemic patients may benefit from NSAID or salicylates. This paper highlights differences between genders. It suggests more concerted effort in men's health and speculates a new factor to investigate in women's health.
UR - http://www.scopus.com/inward/record.url?scp=84873858113&partnerID=8YFLogxK
U2 - 10.1155/2012/795439
DO - 10.1155/2012/795439
M3 - Article
VL - 2012
SP - 1
EP - 5
JO - Anemia
JF - Anemia
SN - 2090-1267
M1 - 795439
ER -